Home > Escp S3 Profiles > AI4Diag
Acronym: 
AI4Diag
Name: 
Strategic Cluster Partnership for increased competitiveness of European Medical Diagnostics SMEs thanks to Artificial Intelligence
Start of Partnership: 
Tuesday, 16 October, 2018
Partnership duration
24 months
Number of partners
5
Number of SMEs involved
600
Partnership's Origin

AI4Diag - News

There is no uploaded content...

AI4Diag - Documents

There is no uploaded content...
Printer-friendly versionPrinter-friendly version
Partnership Objectives: 

AI4diag has a triple ambition: fostering companies’ development, fostering Regions’ co-investments and laying the foundation of a long term collaboration strategy between clusters in order to boost industrial modernisation of diagnostics companies in order to reinforce their international leadership. As a joint Regional-Cluster-Industry Project, AI4Diag will involve all of the local diagnostic and AI actors. After gathering concrete feedback from SMEs on their specific barriers to innovation, skills, cooperation and investment, the consortium aims at structuring regional ecosystems and systematizing joint business cooperation projects and agreements between European Diagnostics and AI companies, including other stakeholders where necessary (hospital centres, manufacturers, venture capitalists, etc.). The global objectives are to : - open up new opportunities for SMEs (even in less developed regions) and help them develop new innovative prediction/detection services with AI - enable technological centres to initiate new collaborations in Europe - enable business organisations to increase skills in companies’ support on that topic - improve the cluster-specific framework conditions in the partners’ Regions - enable Regions to co-invest in the context of this S3.

S3 EU priority areas: 
Emerging industries: 
Medical Devices
Sectoral Industries: 
Other: 

Artificial Intelligence; Big Data; Diagnostics; Precision Medicine

Partnership planned events: 
Target Group: 
Cluster Organisations
Open to SMEs
Type: 
Matchmaking Event
Estimated Date: 
March 2019
Country: 
France
Results expected: 

In order to address these global objectives, AI4Diag has settle 2 specific objectives for the duration of the project still involving at each step all Regions-Cluster-Industry actors: - Building a joint Cluster Partnership Strategy with a common European vision in Artificial Intelligence for Diagnostics, identifying collaboration and investments opportunities and drafting a road map of such joint activities - Implementing joint acceleration activities such as workshops, conferences, training sessions, matchmaking events etc. with a view to foster interregional collaboration and investment, and to bring pilot projects to a more mature phase (demonstrator, prototype or even readyto- market product) AI4DIAG March 8th, 2018 Page 13 of 85 Starting with a bottom-up approach and structuring its actions and objectives on public-private collaboration, we have the ambition that this project serves as a structuring experience to strengthen the clusters and Regions’ partnership and to raise skill level of professional organisations and SMEs to successfully face new challenges in AI for diagnostics industry. The project thus targets smarter and more strategic investments for a more resilient industry and a renewed leadership across Europe and the rest of the world.

Other key partners or networks your partnership is linked with in Europe and in third countries: 
Country: 
Belgium
Name: 
Flanders Bio
Country: 
Italy
Name: 
Tuscany Life Science Cluster
Country: 
Spain
Name: 
Arahealth
Country: 
Estonia
Name: 
Tallinn Science Park Tehnopol

Partnership composition

Name Sector/Technology fields Country Regions Total no. of members Total no. of SME
Tuscany Life Sciences Cluster Biopharmaceuticals, Business Services

Diagnostics, Diagnosis, Medical Technology / Biomedical Engineering

KETSAdvanced manufacturing systems, KETSNanotechnology

Biopharmaceuticals, Medical Devices
Italy Toscana 190 173
Arahealth Biopharmaceuticals

Biochemistry / Biophysics, Pharmaceutical Products / Drugs

Digital Agendae-Health (e.g. healthy ageing), Human health & social work activities:Human health activities (medical services)

Biopharmaceuticals, Digital Industries
Spain Aragón 37 21
EUROBIOMED Biopharmaceuticals

Medical Technology / Biomedical Engineering, Pharmaceutical Products / Drugs

Digital Agendae-Health (e.g. healthy ageing), Human health & social work activities:Human health activities (medical services)

Biopharmaceuticals, Digital Industries
France Provence-Alpes-Côte d'Azur 280 240